产品名称
D-葡萄糖酸钙, 98.0-102.0%, meets USP testing specifications (Not intended for use in preparing injectable dosage forms.)
InChI
1S/2C6H12O7.Ca/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1
InChI key
NEEHYRZPVYRGPP-IYEMJOQQSA-L
SMILES string
OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O[Ca]OC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
biological source
synthetic (organic)
agency
USP/NF
meets USP testing specifications (Not intended for use in preparing injectable dosage forms.)
assay
98.0-102.0% anhydrous basis
98.0-102.0%
form
powder
impurities
<0.002% heavy metal
<3 ppm Arsenic
color
white
application(s)
pharmaceutical (small molecule)
storage temp.
room temp
Quality Level
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Bianca Galateanu et al.
BMC biotechnology, 12, 35-35 (2012-07-04)
The reconstruction of adipose tissue defects is often challenged by the complications that may occur following plastic and reconstructive surgery, including donor-site morbidity, implant migration and foreign body reaction. To overcome these problems, adipose tissue engineering (ATE) using stem cell-based
Jae-Suk Choi et al.
Journal of medicinal food, 16(3), 263-267 (2013-03-13)
Polycalcium is a mixture of Polycan and calcium lactate-gluconate 1:9 (w/w) with demonstrated antiosteoporosis activity in vitro and in vivo studies. These studies were a 4-week open-label, single-center trial to evaluate the efficacy of oral Polycalcium on bone metabolism and
Raul F Silva et al.
BMC veterinary research, 8, 121-121 (2012-07-27)
The clinical use of autologous platelet concentrates (also known as platelet-rich plasma) on the field of regenerative therapy, in the last decade has been the subject of several studies especially in equine medicine and surgery. The objectives of this study
Geoffrey A Block et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 27(7), 1471-1479 (2012-03-31)
This 16-week study evaluated pharmacokinetics and pharmacodynamics of denosumab in 55 subjects with renal function ranging from normal to dialysis-dependent kidney failure. Participants received a single 60-mg subcutaneous dose of denosumab. Kidney function groups were based on calculations using the
Ghada T Ballane et al.
European journal of endocrinology, 166(6), 1113-1120 (2012-03-21)
Hypocalcemia secondary to hypoparathyroidism is a rare cause of congestive heart failure. However, its early recognition and treatment lead to significant improvement in cardiac function. We report a middle-aged woman presenting with symptoms of heart failure with a serum calcium
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持